The DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.
Bacterial genotoxin colibactin promotes colon tumour growth by inducing a senescence-associated secretory phenotype
Abstract
Background: Escherichia coli strains harbouring the pks island ( pks + E. coli ) are often seen in human colorectal tumours and have a carcinogenic effect independent of inflammation in an AOM/IL-10 −/− (azoxymethane/interleukin) mouse model. Objective: To investigate the mechanism sustaining pks + E. coli -induced carcinogenesis. Method: Underlying cell processes were investigated in vitro and in vivo (xenograft model) using intestinal epithelial cells infected by pks + E. coli or by an isogenic mutant defective for pks ( pks − E. coli ). The results were supported by data obtained from an AOM/DSS (azoxymethane/dextran sodium sulphate) colon cancer mouse model and from human colon cancer biopsy specimens colonised by pks + E. coli or pks− E. coli . Results: Colibactin-producing E. coli enhanced tumour growth in both xenograft and AOM/DSS models. Growth was sustained by cellular senescence (a direct consequence of small ubiquitin-like modifier (SUMO)-conjugated p53 accumulation), which was accompanied by the production of hepatocyte growth factor (HGF). The underlying mechanisms involve microRNA-20a-5p, which targets SENP1, a key protein regulating p53 deSUMOylation. These results are consistent with the expression of SENP1, microRNA-20a-5p, HGF and phosphorylation of HGF receptor found in human and mouse colon cancers colonised by pks + E. coli . Conclusion: These data reveal a new paradigm for carcinogenesis, in which colibactin-induced senescence has an important role.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“in several mouse models, other colibactin-producing E. coli have been observed to promote the development of colorectal cancer [125–131]”
From Selection, Comparative Genomics, and Potential Probiotic Features of Escherichia coli 5C, a pks-Negative Strain Isolated from Healthy Infant Donor Feces (2026) · cites this paper as [128]
Citations
Cites
Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008
Ferlay, J., Shin, H., Bray, F., Forman, D., Mathers, C. D., & Parkin, D. M. (2010) · International Journal of Cancer · doi:10.1002/ijc.25516 · Cited by 21,468
A genetic model for colorectal tumorigenesis
Fearon, E. R., & Vogelstein, B. (1990) · Cell · doi:10.1016/0092-8674(90)90186-i · Cited by 12,132
Stratton, M. R., Campbell, P. J., & Futreal, P. A. (2009) · Nature · doi:10.1038/nature07943 · Cited by 3,625
Global burden of cancers attributable to infections in 2008: a review and synthetic analysis
de Martel, C., Ferlay, J., Franceschi, S., Vignat, J., Bray, F., Forman, D., & Plummer, M. (2012) · The Lancet Oncology · doi:10.1016/s1470-2045(12)70137-7 · Cited by 2,540
IKKβ Links Inflammation and Tumorigenesis in a Mouse Model of Colitis-Associated Cancer
Greten, F. R., Eckmann, L., Greten, T. F., Park, J. M., Li, Z.-W., Egan, L. J., Kagnoff, M. F., & Karin, M. (2004) · Cell · doi:10.1016/j.cell.2004.07.013 · Cited by 2,433
c-Myc-regulated microRNAs modulate E2F1 expression
O'Donnell, K. A., Wentzel, E. A., Zeller, K. I., Dang, C. V., & Mendell, J. T. (2005) · Nature · doi:10.1038/nature03677 · Cited by 2,347
Intestinal inflammation targets cancer-inducing activity of the microbiota
Arthur, J. C., Perez-Chanona, E., Mühlbauer, M., Tomkovich, S., Uronis, J. M., Fan, T.-J., Campbell, B. J., Abujamel, T., Dogan, B., Rogers, A. B., et al. (2012) · Science · doi:10.1126/science.1224820 · Cited by 2,263
Cancer epigenomics: DNA methylomes and histone-modification maps
Esteller, M. (2007) · Nature Reviews Genetics · doi:10.1038/nrg2005 · Cited by 2,190
Four faces of cellular senescence
Rodier, F., & Campisi, J. (2011) · Journal of Cell Biology · doi:10.1083/jcb.201009094 · Cited by 2,070
Wu, S., Rhee, K.-J., Albesiano, E., Rabizadeh, S., Wu, X., Yen, H.-R., Huso, D. L., Brancati, F. L., Wick, E., McAllister, F., et al. (2009) · Nature Medicine · doi:10.1038/nm.2015 · Cited by 1,812
Cited by
Sorted by citations
Items 101–200 of 480
Antibiotics and specialized metabolites from the human microbiota
Mousa, W. K., Athar, B., Merwin, N. J., & Magarvey, N. A. (2017) · Natural Product Reports · doi:10.1039/c7np00021a · Cited by 81
Shining a Light on Colibactin Biology
Dougherty, M. W., & Jobin, C. (2021) · Toxins · doi:10.3390/toxins13050346 · Cited by 85
“Driver-passenger” bacteria and their metabolites in the pathogenesis of colorectal cancer
Avril, M., & DePaolo, R. W. (2021) · Gut Microbes · doi:10.1080/19490976.2021.1941710 · Cited by 77
Subversion of host genome integrity by bacterial pathogens
Chumduri, C., Gurumurthy, R. K., Zietlow, R., & Meyer, T. F. (2016) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm.2016.100 · Cited by 81
Straková, N., Kořená, K., & Karpíšková, R. (2021) · Toxicon · doi:10.1016/j.toxicon.2021.04.007 · Cited by 79
Mannucci, A., & Goel, A. (2024) · Molecular Cancer · doi:10.1186/s12943-024-02174-w · Cited by 75
Ohtani, N. (2014) · Seminars in Immunopathology · doi:10.1007/s00281-014-0457-1 · Cited by 76
Barrett's esophagus is associated with a distinct oral microbiome
Snider, E. J., Compres, G., Freedberg, D. E., Giddins, M. J., Khiabanian, H., Lightdale, C. J., Nobel, Y. R., Toussaint, N. C., Uhlemann, A.-C., & Abrams, J. A. (2018) · Clinical and Translational Gastroenterology · doi:10.1038/s41424-018-0005-8 · Cited by 72
Véziant, J., Villéger, R., Barnich, N., & Bonnet, M. (2021) · Cancers · doi:10.3390/cancers13092215 · Cited by 76
Self-citationUbiquitin, SUMO, and NEDD8: Key Targets of Bacterial Pathogens
Ribet, D., & Cossart, P. (2018) · Trends in Cell Biology · doi:10.1016/j.tcb.2018.07.005 · Cited by 73
Tibbs, T., Lopez, L. R., & Arthur, J. C. (2019) · Microbial Cell · doi:10.15698/mic2019.08.685 · Cited by 74
Structure and bioactivity of colibactin
Wernke, K. M., Xue, M., Tirla, A., Kim, C. S., Crawford, J. M., & Herzon, S. B. (2020) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2020.127280 · Cited by 74
Human Gut Microbiota in Health and Selected Cancers
Sędzikowska, A., & Szablewski, L. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222413440 · Cited by 71
Bian, X., Plaza, A., Zhang, Y., & Müller, R. (2015) · Chemical Science · doi:10.1039/c5sc00101c · Cited by 70
Prevalence of pks-positive Escherichia coli in Japanese patients with or without colorectal cancer
Shimpoh, T., Hirata, Y., Ihara, S., Suzuki, N., Kinoshita, H., Hayakawa, Y., Ota, Y., Narita, A., Yoshida, S., Yamada, A., et al. (2017) · Gut Pathogens · doi:10.1186/s13099-017-0185-x · Cited by 66
Bacterial Genotoxin-Induced DNA Damage and Modulation of the Host Immune Microenvironment
Martin, O. C. B., & Frisan, T. (2020) · Toxins · doi:10.3390/toxins12020063 · Cited by 70
Zhu, R., Lang, T., Yan, W., Zhu, X. G., Huang, X. Y., Yin, Q., & Li, Y. (2021) · Advanced Science · doi:10.1002/advs.202003542 · Cited by 65
Escherichia coli ClbS is a colibactin resistance protein
Bossuet‐Greif, N., Dubois, D., Petit, C. R., Tronnet, S., Martín, P., Bonnet, R., Oswald, É., & Nougayrède, J. (2015) · Molecular Microbiology · doi:10.1111/mmi.13272 · Cited by 74
Self-citationCritical Intermediates Reveal New Biosynthetic Events in the Enigmatic Colibactin Pathway
Li, Z., Li, Y., Lai, J. Y. H., Tang, J., Wang, B., Lu, L., Zhu, G., Wu, X., Xu, Y., & Qian, P. (2015) · ChemBioChem · doi:10.1002/cbic.201500239 · Cited by 64
Véziant, J., Gagnière, J., Jouberton, E., Bonnin, V., Sauvanet, P., Pezet, D., Barnich, N., Miot‐Noirault, E., & Bonnet, M. (2016) · World Journal of Clinical Oncology · doi:10.5306/wjco.v7.i3.293 · Cited by 67
Self-citationThe Genotoxin Colibactin Shapes Gut Microbiota in Mice
Tronnet, S., Floch, P., Lucarelli, L., Gaillard, D., Martín, P., Sérino, M., & Oswald, É. (2020) · mSphere · doi:10.1128/msphere.00589-20 · Cited by 71
Colibactin biosynthesis and biological activity depend on the rare aminomalonyl polyketide precursor
Brachmann, A. O., Garcie, C., Wu, V., Martín, P., Ueoka, R., Oswald, É., & Piel, J. (2015) · Chemical Communications · doi:10.1039/c5cc02718g · Cited by 67
Impact of microbiota in colorectal carcinogenesis: lessons from experimental models
Yu, L. C., Wei, S., & Ni, Y. (2018) · Intestinal Research · doi:10.5217/ir.2018.16.3.346 · Cited by 63
Then, C. K., Paillas, S., Wang, X., Hampson, A., & Kiltie, A. E. (2020) · BMC Biology · doi:10.1186/s12915-020-00836-x · Cited by 63
The Role of DNA Damage Response in Dysbiosis-Induced Colorectal Cancer
Rivas-Domínguez, A., Pastor, N., Martínez-López, L., Colón-Pérez, J., Bermúdez, B., & Orta, M. L. (2021) · Cells · doi:10.3390/cells10081934 · Cited by 63
Early settlers: which E. coli strains do you not want at birth?
Secher, T., Brehin, C., & Oswald, E. (2016) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00091.2016 · Cited by 58
The Polyamine Spermidine Modulates the Production of the Bacterial Genotoxin Colibactin
Chagneau, C. V., Garcie, C., Bossuet‐Greif, N., Tronnet, S., Brachmann, A. O., Piel, J., Nougayrède, J., Martín, P., & Oswald, É. (2019) · mSphere · doi:10.1128/msphere.00414-19 · Cited by 65
Microbiome and colorectal carcinogenesis: Linked mechanisms and racial differences
Tortora, S. C., Bodiwala, V., Quinn, A., Martello, L. A., & Vignesh, S. (2022) · World Journal of Gastrointestinal Oncology · doi:10.4251/wjgo.v14.i2.375 · Cited by 60
Zha, L., Wilson, M. R., Brotherton, C. A., & Balskus, E. P. (2016) · ACS Chemical Biology · doi:10.1021/acschembio.6b00014 · Cited by 63
Microbiota and Colorectal Cancer: From Gut to Bedside
Silva, M. G., Brunner, V., & Tschurtschenthaler, M. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.760280 · Cited by 61
miRNA–Microbiota Interaction in Gut Homeostasis and Colorectal Cancer
Dong, J., Tai, J. W., & Lu, L. (2019) · Trends in cancer · doi:10.1016/j.trecan.2019.08.003 · Cited by 57
Food, microbiome and colorectal cancer
Niederreiter, L., Adolph, T. E., & Tilg, H. (2018) · Digestive and Liver Disease · doi:10.1016/j.dld.2018.03.030 · Cited by 56
Gut Microbiota Influences Experimental Outcomes in Mouse Models of Colorectal Cancer
Leystra, A. A., & Clapper, M. L. (2019) · Genes · doi:10.3390/genes10110900 · Cited by 61
Contribution of pks+ Escherichia coli (E. coli) to Colon Carcinogenesis
Sadeghi, M., Mestivier, D., & Sobhani, I. (2024) · Microorganisms · doi:10.3390/microorganisms12061111 · Cited by 58
Garcie, C., Tronnet, S., Garénaux, A., McCarthy, A. J., Brachmann, A. O., Pénary, M., Houle, S., Nougayrède, J., Piel, J., Taylor, P. W., et al. (2016) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiw294 · Cited by 62
Gagnière, J., Bonnin, V., Jarrousse, A., Cardamone, E., Agus, A., Uhrhammer, N. A., Sauvanet, P., Déchelotte, P., Barnich, N., Bonnet, R., et al. (2017) · Clinical Science · doi:10.1042/cs20160876 · Cited by 62
Self-citationLiu, K., Yang, X., Zeng, M., Yuan, Y., Sun, J., He, P., Sun, J., Xie, Q., Chang, X., Zhang, S., et al. (2021) · Disease Markers · doi:10.1155/2021/1171239 · Cited by 55
Auvray, F., Perrat, A., Arimizu, Y., Chagneau, C. V., Bossuet‐Greif, N., Massip, C., Brugère, H., Nougayrède, J., Hayashi, T., Branchu, P., et al. (2021) · Microbial Genomics · doi:10.1099/mgen.0.000579 · Cited by 60
A small molecule inhibitor prevents gut bacterial genotoxin production
Volpe, M. R., Velilla, J. A., Daniel-Ivad, M., Yao, J. J., Stornetta, A., Villalta, P. W., Huang, H., Bachovchin, D. A., Balbo, S., Gaudet, R., et al. (2022) · Nature Chemical Biology · doi:10.1038/s41589-022-01147-8 · Cited by 55
Microbiota in cancer: current understandings and future perspectives
Yao, Y., Zhu, Y., Chen, K., Chen, J., Li, Y., Li, D., & Wei, P. (2026) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-025-02335-3 · Cited by 56
Iron Homeostasis Regulates the Genotoxicity of Escherichia coli That Produces Colibactin
Tronnet, S., Garcie, C., Rehm, N., Dobrindt, U., Oswald, É., & Martín, P. (2016) · Infection and Immunity · doi:10.1128/iai.00659-16 · Cited by 59
Lao, Y., Yang, K., Wang, Z., Sun, X., Zou, Q., Yu, X., Cheng, J., Tong, X., Yeh, E. T. H., Yang, J., et al. (2018) · Journal of Biological Chemistry · doi:10.1074/jbc.m117.816769 · Cited by 51
Potential role of Escherichia coli DNA mismatch repair proteins in colon cancer
Khan, S. (2015) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2015.05.002 · Cited by 50
Bacterial genotoxins induce T cell senescence
Mathiasen, S. L., Gall-Mas, L., Pateras, I. S., Theodorou, S. D. P., Namini, M. R. J., Hansen, M., Martin, O. C. B., Vadivel, C. K., Ntostoglou, K., Butter, D., et al. (2021) · Cell Reports · doi:10.1016/j.celrep.2021.109220 · Cited by 49
Marongiu, L., & Allgayer, H. (2021) · Molecular Oncology · doi:10.1002/1878-0261.13100 · Cited by 49
Gut Microbiota–MicroRNA Interactions in Intestinal Homeostasis and Cancer Development
Nikolaieva, N., Ševčíková, A., Omelka, R., Martiniaková, M., Mego, M., & Čierniková, S. (2022) · Microorganisms · doi:10.3390/microorganisms11010107 · Cited by 47
Genotoxins: The Mechanistic Links between Escherichia coli and Colorectal Cancer
Wang, Y., & Fu, K. (2023) · Cancers · doi:10.3390/cancers15041152 · Cited by 51
Potential role of gut microbiota in prostate cancer: immunity, metabolites, pathways of action?
Zha, C., Peng, Z., Huang, K., Tang, K., Wang, Q., Zhu, L. J., Che, B., Li, W., Xu, S., Huang, T., et al. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2023.1196217 · Cited by 49
Crosstalk between gut microbiota and cellular senescence: a vicious cycle leading to aging gut
Kawamoto, S., & Hara, E. (2024) · Trends in Cell Biology · doi:10.1016/j.tcb.2023.12.004 · Cited by 47
Morgan, R. N., Saleh, S. E., Farrag, H. A., & Aboulwafa, M. (2019) · Gut Pathogens · doi:10.1186/s13099-019-0304-y · Cited by 48
RetractedBacterial signatures and their inflammatory potentials associated with prostate cancer
Brüggemann, H., & Al‐Zeer, M. A. (2020) · Apmis · doi:10.1111/apm.13021 · Cited by 48
Kim, S. H., & Lim, Y. J. (2021) · Intestinal Research · doi:10.5217/ir.2021.00034 · Cited by 47
Bacterial protein toxins in human cancers
Rosadi, F., Fiorentini, C., & Fabbri, A. (2015) · Pathogens and Disease · doi:10.1093/femspd/ftv105 · Cited by 46
Uropathogenic E. coli induces DNA damage in the bladder
Chagneau, C. V., Massip, C., Bossuet‐Greif, N., Fremez, C., Motta, J., Shima, A., Besson‐Fournier, C., Faouder, P. L., Cénac, N., Roth, M., et al. (2021) · PLoS Pathogens · doi:10.1371/journal.ppat.1009310 · Cited by 50
Salesse, L., Lucas, C., Hoang, M. H. T., Sauvanet, P., Rézard, A., Rosenstiel, P. C., Damon‐Soubeyrand, C., Barnich, N., Godfraind, C., Dalmasso, G., et al. (2021) · Cancers · doi:10.3390/cancers13092060 · Cited by 53
Self-citationDe-coding the complex role of microbial metabolites in cancer
Escriva, P. P., Bernardino, C. C. T., & Letellier, E. (2025) · Cell Reports · doi:10.1016/j.celrep.2025.115358 · Cited by 48
Exploring the microbiota to better understand gastrointestinal cancers physiology
Panebianco, C., Potenza, A., Andriulli, A., & Pazienza, V. (2018) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm-2017-1163 · Cited by 46
Escherichia coli and Colorectal Cancer: Unfolding the Enigmatic Relationship
Rezaee, M. A., Nouri, R., Hasani, A., Shirazi, K. M., Alivand, M. R., Sepehri, B., Sotoodeh, S., & Hemmati, F. (2021) · Current Pharmaceutical Biotechnology · doi:10.2174/1389201022666210910094827 · Cited by 47
Gao, Y., Zhu, Z., & Sun, F. (2022) · Synthetic and Systems Biotechnology · doi:10.1016/j.synbio.2022.01.005 · Cited by 45
Thakur, B. K., Malaisé, Y., Choudhury, S. R., Neustaeter, A., Turpin, W., Streutker, C., Copeland, J. K., Wong, E. O. Y., Navarre, W. W., Guttman, D. S., et al. (2025) · Nature Microbiology · doi:10.1038/s41564-025-01938-4 · Cited by 46
The Four Horsemen in Colon Cancer
Hernández-Luna, M. A., López-Briones, S., & Lurı́a-Pérez, R. (2019) · Journal of Oncology · doi:10.1155/2019/5636272 · Cited by 45
Shamekhi, S., Lotfi, H., Abdolalizadeh, J., Bonabi, E., & Zarghami, N. (2020) · Clinical & Translational Oncology · doi:10.1007/s12094-019-02270-0 · Cited by 44
Dalmasso, G., Cougnoux, A., Faïs, T., Bonnin, V., Mottet-Auselo, B., Nguyen, H. T. T., Sauvanet, P., Barnich, N., Jary, M., Pezet, D., et al. (2024) · Gut Microbes · doi:10.1080/19490976.2024.2310215 · Cited by 43
Self-citationSarshar, M., Scribano, D., Marazzato, M., Ambrosi, C., Aprea, M. R., Aleandri, M., Pronio, A., Longhi, C., Nicoletti, M., Zagaglia, C., et al. (2017) · Microbial Pathogenesis · doi:10.1016/j.micpath.2017.10.009 · Cited by 43
Effect of non-enzymatic glycosylation in the epigenetics of cancer
Rehman, S., Aatif, M., Rafi, Z., Khan, M. Y., Shahab, U., Ahmad, S., & Farhan, M. (2020) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2020.11.019 · Cited by 43
Leung, A., Tsoi, H., & Yu, J. Q. (2015) · Expert Review of Gastroenterology & Hepatology · doi:10.1586/17474124.2015.1001745 · Cited by 43
Molecular Basis of Gut Microbiome-Associated Colorectal Cancer: A Synthetic Perspective
Healy, A. R., & Herzon, S. B. (2017) · Journal of the American Chemical Society · doi:10.1021/jacs.7b07807 · Cited by 46
Feng, Y., Mannion, A. J., Madden, C. M., Swennes, A. G., Townes, C., Byrd, C. P., Marini, R. P., & Fox, J. G. (2017) · Gut Pathogens · doi:10.1186/s13099-017-0220-y · Cited by 42
The pks island: a bacterial Swiss army knife? Colibactin: beyond DNA damage and cancer
Chagneau, C. V., Payros, D., Tang-Fichaux, M., Auvray, F., Nougayrède, J., & Oswald, É. (2022) · Trends in Microbiology · doi:10.1016/j.tim.2022.05.010 · Cited by 43
Dalmasso, G., Nguyen, H. T. T., Faïs, T., Massier, S., Barnich, N., Delmas, J., & Bonnet, R. (2019) · Cells · doi:10.3390/cells8010035 · Cited by 41
Self-citationThe gut microbiome and frailty
Piggott, D. A., & Tuddenham, S. (2020) · Translational research · doi:10.1016/j.trsl.2020.03.012 · Cited by 43
Human microbiome and prostate cancer development: current insights into the prevention and treatment
Moghadam, S. O., & Momeni, S. A. (2020) · Frontiers of Medicine · doi:10.1007/s11684-019-0731-7 · Cited by 41
Yu, L. C., Wei, S., Li, Y.-H., Lin, P.-Y., Chang, X., Weng, J.-P., Shue, Y.-W., Lai, L., Wang, J., Jeng, Y., et al. (2021) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2021.08.007 · Cited by 40
López‐Siles, M., Camprubí-Font, C., del Pulgar, E. M. G., Sàbat, M., Busquets, D., Sanz, Y., & Martínez-Medina, M. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.748839 · Cited by 42
ClbR Is the Key Transcriptional Activator of Colibactin Gene Expression in Escherichia coli
Wallenstein, A., Rehm, N., Brinkmann, M., Selle, M., Bossuet‐Greif, N., Sauer, D., Bunk, B., Spröer, C., Wami, H. T., Homburg, S., et al. (2020) · mSphere · doi:10.1128/msphere.00591-20 · Cited by 45
Senescence and Host–Pathogen Interactions
Humphreys, D., ElGhazaly, M., & Frisan, T. (2020) · Cells · doi:10.3390/cells9071747 · Cited by 43
García, A., & Fox, J. G. (2021) · Comparative Medicine · doi:10.30802/aalas-cm-20-000054 · Cited by 46
Pathobionts in the tumour microbiota predict survival following resection for colorectal cancer
Alexander, J. L., Posma, J. M., Scott, A. J., Poynter, L., Mason, S., Dória, M. L., Herendi, L., Roberts, L., McDonald, J. A. K., Cameron, S. J. S., et al. (2023) · Microbiome · doi:10.1186/s40168-023-01518-w · Cited by 40
Oral and intestinal bacterial exotoxins: Potential linked to carcinogenesis
Silbergleit, M., Vasquez, A. A., Miller, C. J., Sun, J., & Kato, I. (2020) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2020.02.004 · Cited by 40
Tang-Fichaux, M., Chagneau, C. V., Bossuet‐Greif, N., Nougayrède, J., Oswald, É., & Branchu, P. (2020) · mSphere · doi:10.1128/msphere.01195-20 · Cited by 45
Marongiu, L., Landry, J. J. M., Rausch, T., Abba, M. L., Delécluse, S., Delecluse, H., & Allgayer, H. (2021) · Molecular Oncology · doi:10.1002/1878-0261.13070 · Cited by 40
Guntaka, N. S., Healy, A. R., Crawford, J. M., Herzon, S. B., & Bruner, S. D. (2017) · ACS Chemical Biology · doi:10.1021/acschembio.7b00479 · Cited by 42
Colorectal carcinogenesis: an archetype of gut microbiota–host interaction
Alexander, J. L., Scott, A. J., Pouncey, A. L., Marchesi, J. R., Kinross, J. K., & TEARE, J. P. (2018) · ecancermedicalscience · doi:10.3332/ecancer.2018.865 · Cited by 38
Elsalem, L., Jum’ah, A. A., Alfaqih, M. A., & Aloudat, O. (2020) · Clinical and Experimental Gastroenterology · doi:10.2147/ceg.s243337 · Cited by 38
Microbiota Alterations and Their Association with Oncogenomic Changes in Pancreatic Cancer Patients
Sammallahti, H., Kokkola, A., Rezasoltani, S., Ghanbari, R., Aghdaei, H. A., Knuutila, S., Puolakkainen, P. A., & Sarhadi, V. K. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222312978 · Cited by 40
Autoimmune diseases exhibit shared alterations in the gut microbiota
Wang, T., Sternes, P. R., Guo, X.-K., Zhao, H., Xu, C., & Xu, H. (2023) · Rheumatology · doi:10.1093/rheumatology/kead364 · Cited by 40
Molecular Paths Linking Metabolic Diseases, Gut Microbiota Dysbiosis and Enterobacteria Infections
Sérino, M. (2018) · Journal of Molecular Biology · doi:10.1016/j.jmb.2018.01.010 · Cited by 37
Host–MicroRNA–Microbiota Interactions in Colorectal Cancer
Yuan, C., Steer, C. J., & Subramanian, S. (2019) · Genes · doi:10.3390/genes10040270 · Cited by 38
Khan, S., Zaidi, S., Alouffi, A., Hassan, I., Imran, A., & Khan, R. A. (2020) · ACS Omega · doi:10.1021/acsomega.9b04042 · Cited by 36
Wami, H. T., Wallenstein, A., Sauer, D., Stoll, M., von Bünau, R., Oswald, É., Müller, R., & Dobrindt, U. (2021) · Microbial Genomics · doi:10.1099/mgen.0.000577 · Cited by 41
Bacterial Involvement in Progression and Metastasis of Colorectal Neoplasia
Seely, K. D., Morgan, A. D., Hagenstein, L. D., Florey, G. M., & Small, J. M. (2022) · Cancers · doi:10.3390/cancers14041019 · Cited by 36
Casimiro‐Soriguer, C. S., Loucera, C., Peña-Chilet, M., & Dopazo, J. (2022) · Scientific Reports · doi:10.1038/s41598-021-04182-y · Cited by 38
Biosynthesis and bioactivities of microbial genotoxin colibactins
Tang, J., Liu, X., Ye, W., Li, Z., & Qian, P. (2022) · Natural Product Reports · doi:10.1039/d1np00050k · Cited by 36
Chang, L., Hu, Y. W., Fu, Y., Zhou, T., You, J., Du, J., Zheng, L., Cao, J., Ying, M., Dai, X., et al. (2019) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2019.03.001 · Cited by 34
Role of gut microbiota and bacterial metabolites in mucins of colorectal cancer
Ming, G., Yin, W., Zhang, J., Yin, J., Tang, X., Ling, J., Tang, Z., Yin, W., Wang, X., Ni, Q., et al. (2023) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2023.1119992 · Cited by 33
Cruz, B. C. D. S., Duarte, V. D. S., Giacomini, A., Corich, V., de Paula, S. O., Fialho, L. D. S., Guimarães, V. M., Ferreira, C. L. D. L. F., & Pelúzio, M. D. C. G. (2020) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-020-10863-x · Cited by 34
Viennois, É., & Chassaing, B. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22052602 · Cited by 33
Emerging role of microbiota in immunomodulation and cancer immunotherapy
Singh, R. P., Bashir, H., & Kumar, R. (2020) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2020.06.008 · Cited by 34
Dong, S., Li, W., Li, X., Wang, Z., Zhou, C., Shi, H., He, R., Chen, C., & Zhou, W. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1038650 · Cited by 33
Tronnet, S., Garcie, C., Brachmann, A. O., Piel, J., Oswald, É., & Martín, P. (2017) · Pathogens and Disease · doi:10.1093/femspd/ftx066 · Cited by 38
Metadata
- Authors
- Cougnoux, A., Dalmasso, G., Martinez, R., Buc, E., Delmas, J., Gibold, L., Sauvanet, P., Darcha, C., Déchelotte, P., Bonnet, M., Pezet, D., Wodrich, H., Darfeuille-Michaud, A., & Bonnet, R.
- Affiliations
- Inserm (FR)
- Centre National de la Recherche Scientifique (FR)
- Centre Hospitalier Universitaire de Clermont-Ferrand (FR)
- Clermont Université, UMR 1071 Inserm/Université d'Auvergne, Clermont-Ferrand, France
- Corresponding author
- Bonnet, Richard
- ORCID
- Venue
- Gut
- Publisher
- BMJ
- Published
- 2014-03-21
- Volume
- 63
- Issue
- 12
- Pages
- 1932-1942
- ISSN
- 0017-5749 (ISSN-L)
- 1468-3288
- OpenAlex
- W2111725588
- Semantic Scholar
- 15f9aae86af823cd6aad2d6681907d71cc828598
- Cited by
- 486
- References
- 44
- Citations by year
- 2026: 34 · 2025: 35 · 2024: 43 · 2023: 46 · 2022: 54 · 2021: 68 · 2020: 50 · 2019: 37 · 2018: 35 · 2017: 27 · 2016: 25 · 2015: 22 · 2014: 10
- FWCI
- 19.73
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Gut (publishedVersion)
- PubMed (publishedVersion)
- HAL (submittedVersion)
- HighWire Press Open Archive (submittedVersion)
- Funders
- Institut National de la Santé et de la Recherche Médicale
- Ligue Contre le Cancer
- Institut National de la Recherche Agronomique
- Centre Hospitalier Universitaire de Clermont-Ferrand
- Topics
- Life Sciences › Immunology and Microbiology › Microbiology › Escherichia coli research studies
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biotechnology › Bacterial Cancer Therapy
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Keywords
- colibactin, Escherichia coli, pks island, colorectal cancer, tumor growth, cellular senescence, senescence-associated secretory phenotype, hepatocyte growth factor, SENP1, SUMOylation, bacterial carcinogenesis, AOM/DSS model, xenograft models
- MeSH terms
- Animals, Colonic Neoplasms, Cysteine Endopeptidases, Escherichia coli, Humans, Mutagens, Mutation, Neoplasms, Experimental, Nuclear Proteins, Endopeptidases, Peptides, Cellular Senescence, Hepatocyte Growth Factor, Proto-Oncogene Proteins c-met, Mice, Polyketides, Carcinogenesis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review